免費咨詢(xún)熱線(xiàn)：
15522676233
厄達替尼 Erdafitinib Erdafitinib, also known as JNJ-42756493, is a potent and selective orally bioavailable, pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
米哚妥林 Midostaurin Midostaurin, also known as PKC-412, PKC-412A and CGP 41251; is a synthetic indolocarbazole multikinase inhibitor with potential antiangiogenic and antineoplastic activities.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
吉列替尼 Gilteritinib Gilteritinib, also known as ASP2215, is a potent FLT3/AXL inhibitor, which showed potent antileukemic activity against AML with either or both FLT3-ITD and FLT3-D835 mutations.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
來(lái)那替尼 Neratinib Neratinib, also known as HKI-272 or PB272, is an orally available, irreversible inhibitor of the HER-2 receptor tyrosine kinase with potential antineoplastic activity.
更新時(shí)間：2023-07-12
廠(chǎng)商性質(zhì)：代理商
微信掃一掃
